This profile hasn't yet passed our validation checks
Submit your email to push it up the queue
Astrazeneca Sweden Investments Limited
AstraZeneca Sweden Investments Limited, a subsidiary of the global biopharmaceutical giant AstraZeneca, is headquartered in Great Britain. Established in 1999, the company has made significant strides in the pharmaceutical industry, focusing on innovative medicines across various therapeutic areas, including oncology, cardiovascular, and respiratory diseases. With a strong presence in Sweden and other major operational regions, AstraZeneca is renowned for its commitment to research and development, leading to groundbreaking treatments that address unmet medical needs. The company’s core products, such as Tagrisso and Symbicort, are distinguished by their efficacy and unique mechanisms of action. AstraZeneca's market position is bolstered by its robust pipeline and notable achievements, including numerous awards for innovation and excellence in healthcare. As a leader in the biopharmaceutical sector, AstraZeneca Sweden Investments Limited continues to shape the future of medicine through its dedication to scientific advancement and patient care.
DitchCarbon Score
How does Astrazeneca Sweden Investments Limited's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Business Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Astrazeneca Sweden Investments Limited's score of 99 is higher than 99% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Astrazeneca Sweden Investments Limited, headquartered in Great Britain, currently does not report specific carbon emissions data, as indicated by the absence of emissions figures. The company is a current subsidiary of AstraZeneca PLC, which cascades its climate commitments and emissions data down through its corporate structure. AstraZeneca PLC has set ambitious climate targets, including commitments to reduce greenhouse gas emissions across its operations. These targets are part of a broader strategy to achieve net-zero emissions by 2025 for its direct operations (Scope 1 and 2) and by 2030 for its value chain (Scope 3). The initiatives and targets from AstraZeneca PLC, including those reported to the Science Based Targets initiative (SBTi) and the Carbon Disclosure Project (CDP), are inherited by Astrazeneca Sweden Investments Limited at the fourth cascade level. While specific reduction targets for Astrazeneca Sweden Investments Limited are not detailed, the overarching commitments from its parent company reflect a strong dedication to sustainability and climate action within the pharmaceutical industry.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2015 | 2016 | 2017 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|
| Scope 1 | 298,498,000 | 000,000,000 | 000,000,000 | - | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 |
| Scope 2 | 322,319,000 | 000,000,000 | 000,000,000 | - | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 |
| Scope 3 | - | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Astrazeneca Sweden Investments Limited is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
